Increased kynurenic acid in the brain after neonatal asphyxia.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Life Science

• Publication date

  2001-08-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(01)01215-2PMID 11521749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of kynurenic acid levels in the developing rat brain

  2005cited by this paper
• 2-ketoglutarate dehydrogenase deficiency with intermittent 2-ketoglutaric aciduria.

  2000cited by this paper
• Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain

  2000cited by this paper
• Kynurenic Acid in Brain and Cerebrospinal Fluid of Fetal, Newborn, and Adult Sheep and Effects of Placental Embolization

  1999cited by this paper
• Delayed neuronal death following perinatal asphyxia in rat

  1997cited by this paper
• Characterization of rat brain kynurenine aminotransferases I and II

  1997cited by this paper
• Short- and long-term effects of perinatal asphyxia on monoamine, amino acid and glycolysis product levels measured in the basal ganglia of the rat.

  1997cited by this paper
• Effect of perinatal asphyxia on systemic and intracerebral pH and glycolysis metabolism in the rat.

  1997cited by this paper
• Decrease of Brain Protein Kinase C, Protein Kinase A, and Cyclin-Dependent Kinase Correlating with pH Precedes Neuronal Death in Neonatal Asphyxia

  1997cited by this paper
• Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats.

  1995cited by this paper
• Comparison of the Neurochemical and Behavioral Effects Resulting from the Inhibition of Kynurenine Hydroxylase and/or Kynureninase

  1995cited by this paper
• Mechanism of Delayed Increases in Kynurenine Pathway Metabolism in Damaged Brain Regions Following Transient Cerebral Ischemia

  1993cited by this paper
• Prevention of mortality induced by perinatal asphyxia: Hypothermia or glutamate antagonism?

  1993cited by this paper
• Neuropharmacology of quinolinic and kynurenic acids.

  1993cited by this paper
• Developmental changes in brain kynurenic acid concentrations.

  1992cited by this paper
• Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats.

  1991cited by this paper
• Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection.

  1990cited by this paper
• Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line.

  1989cited by this paper
• Identification and quantification of kynurenic acid in human brain tissue.

  1988cited by this paper
• Presence of Kynurenic Acid in the Mammalian Brain

  1988cited by this paper
• The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection.

  1988cited by this paper
• Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia.

  1987cited by this paper
• MK-801 protects the neonatal brain from hypoxic-ischemic damage.

  1987cited by this paper
• The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain.

  1986cited by this paper
• Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.

  1984cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Tryptophan metabolites as biomarkers to predict the severity and prognosis of acute ischemic stroke patients

  2025cites this paper
• Disturbances in amino acid metabolism in obstructive sleep apnea–hypopnea syndrome: insights from a cross-sectional study

  2025cites this paper
• Importance of Modulating Kynurenic Acid Metabolism—Approaches for the Treatment of Dementia

  2025cites this paper
• Differential Effects of Hypothermia and SZR72 on Cerebral Kynurenine and Kynurenic Acid in a Piglet Model of Hypoxic–Ischemic Encephalopathy

  2023cites this paper
• Small molecule biomarkers for neonatal hypoxic ischemic encephalopathy.

  2020cites this paper
• Neuronal proteins as targets of 3-hydroxykynurenine: Implications in neurodegenerative diseases.

  2019cites this paper
• Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice

  2019cites this paper
• Genetic and perinatal risk factors for movement disorders

  2017cites this paper
• Reduced Glutamatergic Neurotransmission as Possible Indicator of Unfavorable Prognosis

  2017cites this paper
• 25 years of research on global asphyxia in the immature rat brain

  2017cites this paper
• Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

  2017cites this paper
• Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria

  2016cites this paper
• Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.

  2016cites this paper
• Is tryptophan metabolism involved in sleep apnea-related cardiovascular co-morbidities and cancer progression?

  2015cites this paper
• Carotid surgery affects plasma kynurenic acid concentration: A pilot study

  2014cites this paper
• Stroke Patients after repetitive Transcranial Magnetic Stimulation (rTMS) - Alterations of Tryptophan Metabolites in the Serum

  2014cites this paper
• he kynurenine pathway contributes to long-term neuropsychological hanges in experimental pneumococcal meningitis

  2014cites this paper
• Short- and long-term changes in extracellular glutamate and acetylcholine concentrations in the rat hippocampus following hypoxia.

  2012cites this paper
• Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection

  2012cites this paper
• Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

  2012cites this paper
• The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease

  2011cites this paper
• Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery

  2011cites this paper
• Structure, expression, and function of kynurenine aminotransferases in human and rodent brains

  2010cites this paper
• Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as “Glia Depressing Factor” (GDF)

  2010cites this paper
• Cerebrolysin lowers kynurenic acid formation--an in vitro study.

  2009cites this paper
• Altered kynurenine metabolism correlates with infarct volume in stroke

  2007cites this paper
• Perinatal kynurenine 3‐hydroxylase inhibition in rodents: Pathophysiological implications

  2007cites this paper
• Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs.

  2006cites this paper
• Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria.

  2003cites this paper
• Kynurenines and the respiratory parameters on rat heart mitochondria.

  2003cites this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cites this paper
• International Journal of Tryptophan Research Kynurenic Acid Metabolism in Various Types of Brain Pathology in Hiv-1 Infected Patients

  year unknowncites this paper